Mario Cortina - Senior Multi-Specialty Portfolio Specialist - Sumitomo Pharma America (formerly Sunovion Pharmaceuticals | LinkedIn
![Sunovion Pharmaceuticals Inc. - Sunovion Announces Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution Now Available in the U.S. for the Treatment of COPD Sunovion Pharmaceuticals Inc. - Sunovion Announces Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution Now Available in the U.S. for the Treatment of COPD](https://s23.q4cdn.com/866595044/files/doc_events/2018/04/1/svn_pos_clr_rgb.jpg)
Sunovion Pharmaceuticals Inc. - Sunovion Announces Lonhala™ Magnair™ (glycopyrrolate) Inhalation Solution Now Available in the U.S. for the Treatment of COPD
![Deceptive Promotions Used by Sunovion to Hype Respiratory Drug Brovana, FDA Charges - Parker Waichman LLP Deceptive Promotions Used by Sunovion to Hype Respiratory Drug Brovana, FDA Charges - Parker Waichman LLP](https://www.yourlawyer.com/wp-content/uploads/2016/12/Sunovian-Pharmaceuticals-Brovana-Lawsuits.jpg)
Deceptive Promotions Used by Sunovion to Hype Respiratory Drug Brovana, FDA Charges - Parker Waichman LLP
![Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/2997e66e-d175-4a26-b961-da3c9d4f7b17/bcp12517-fig-0001-m.jpg)
Efficacy and safety of nebulized glycopyrrolate for administration using a high efficiency nebulizer in patients with chronic obstructive pulmonary disease - Leaker - 2015 - British Journal of Clinical Pharmacology - Wiley Online Library
![Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD | Business Wire Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD | Business Wire](https://mms.businesswire.com/media/20171205006502/en/628187/4/3135393_Lonhala_Magnair_Logo_25mcg_1mL.jpg)
Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD | Business Wire
![Sunovion Pharmaceuticals Inc. - Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD Sunovion Pharmaceuticals Inc. - Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD](https://s23.q4cdn.com/866595044/files/doc_events/2017/12/1/LM_NebulizerSystem.jpg)
Sunovion Pharmaceuticals Inc. - Sunovion Receives FDA Approval for Lonhala™ Magnair™ Inhalation Solution to Treat COPD
![Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease - Roy A. Pleasants, 2019 Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease - Roy A. Pleasants, 2019](https://journals.sagepub.com/cms/10.1177/1060028018798753/asset/images/large/10.1177_1060028018798753-fig2.jpeg)